Morgan Stanley Portfolio holdings
Morgan Stanley is a financial services company with divisions for institutional services, wealth management and investment management. Its institutional arm advises large institutions on strategy and raising capital, its wealth arm serves individuals and family offices and runs the E-Trade self-directed investing service, and its investment arm offers hedge fund, real estate and infrastructure strategies as well as private equity and private credit. It was founded in 1935 by Harold Stanley and Henry Sturgis Morgan, who was J.P. Morgan's grandson, both leaving J.P. Morgan & Co., after the Glass-Steagall Act forced commercial and investment banking apart. In 1997 it merged with Dean Witter Discover, the financial services business Sears had spun off, and it went back to the Morgan Stanley name in 2001. In 2009 its wealth business was merged with Citigroup's Smith Barney, and in 2012 Morgan Stanley bought a larger share of that venture from Citigroup. Morgan Stanley later bought E-Trade in 2020 and Eaton Vance in 2021.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Herc Holdings
HRI
$5.55B
| $40.1M | ﹤0.01% |
279,479
-95,061
| -25% | -$12.3M |
2013 Q2
52 quarters
|
|
2452
Ambev
ABEV
$41B
| $40M | ﹤0.01% |
12,751,317
+2,430,011
| +24% | +$7.6M |
2013 Q4
50 quarters
|
|
2453
DNP Select Income Fund
DNP
$3.85B
| $40M | ﹤0.01% |
3,706,483
-67,520
| -2% | -$720K |
2013 Q2
52 quarters
|
|
2454
Northwest Natural Holdings
NWN
$2.1B
| $40M | ﹤0.01% |
814,327
-17,028
| -2% | -$872K |
2013 Q2
52 quarters
|
|
2455
Lionsgate Studios
LION
$3.7B
| $39.8M | ﹤0.01% |
2,596,799
+1,700,722
| +190% | +$22M |
2024 Q3
7 quarters
|
|
2456
Ziff Davis
ZD
$1.88B
| $39.7M | ﹤0.01% |
758,679
+146,934
| +24% | +$6.65M |
2013 Q2
52 quarters
|
|
2457
Eagle Capital Select Equity ETF
EAGL
$4.88B
| $39.7M | ﹤0.01% |
1,234,503
+73,699
| +6% | +$2.38M |
2025 Q1
5 quarters
|
|
2458
Banc of California
BANC
$2.89B
| $39.6M | ﹤0.01% |
1,940,174
-249,253
| -11% | -$4.75M |
2013 Q3
51 quarters
|
|
2459
Sarepta Therapeutics
SRPT
$1.97B
| $39.6M | ﹤0.01% |
2,202,641
-394,352
| -15% | -$7.46M |
2013 Q2
52 quarters
|
|
2460
Invesco International BuyBack Achievers ETF
IPKW
$551M
| $39.6M | ﹤0.01% |
702,544
+40,501
| +6% | +$2.35M |
2014 Q1
49 quarters
|
|
2461
Warrior Met Coal
HCC
$4.54B
| $39.5M | ﹤0.01% |
487,017
-74,964
| -13% | -$6.78M |
2017 Q2
36 quarters
|
|
2462
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$890M
| $39.5M | ﹤0.01% |
1,514,889
+17,224
| +1% | +$449K |
2025 Q1
5 quarters
|
|
2463
Comstock Resources
CRK
$4.32B
| $39.4M | ﹤0.01% |
2,637,411
+1,069,310
| +68% | +$16.3M |
2013 Q2
52 quarters
|
|
2464
Aurinia Pharmaceuticals
AUPH
$2.22B
| $39.2M | ﹤0.01% |
2,308,244
+75,696
| +3% | +$1.21M |
2014 Q3
47 quarters
|
|
2465
American Eagle Outfitters
AEO
$3.29B
| $39.2M | ﹤0.01% |
2,276,560
-149,801
| -6% | -$2.59M |
2013 Q2
52 quarters
|
|
2466
Nuveen Municipal Credit Income Fund
NZF
$2.23B
| $39.2M | ﹤0.01% |
3,087,546
+47,319
| +2% | +$594K |
2013 Q2
52 quarters
|
|
2467
Versigent PLC
VGNT
$2.91B
| $39.1M | ﹤0.01% |
931,190
+930,235
| +97,407% | +$37.1M |
2026 Q1
1 quarter
|
|
2468
ManpowerGroup
MAN
$2.15B
| $39.1M | ﹤0.01% |
1,157,736
-224,517
| -16% | -$6.87M |
2013 Q2
52 quarters
|
|
2469
Genworth Financial
GNW
$3.32B
| $39.1M | ﹤0.01% |
4,125,023
+206,959
| +5% | +$1.84M |
2013 Q2
52 quarters
|
|
2470
VEON
VEON
$5.68B
| $39M | ﹤0.01% |
747,852
-20,269
| -3% | -$1.06M |
2013 Q2
52 quarters
|
|
2471
First Trust Long Duration Opportunities ETF
LGOV
$614M
| $39M | ﹤0.01% |
1,824,095
+131,832
| +8% | +$2.83M |
2023 Q4
10 quarters
|
|
2472
V2X
VVX
$2.52B
| $39M | ﹤0.01% |
522,930
+143,735
| +38% | +$10.7M |
2014 Q3
47 quarters
|
|
2473
Pacer Trendpilot US Mid Cap ETF
PTMC
$370M
| $38.9M | ﹤0.01% |
930,207
-57,347
| -6% | -$2.28M |
2015 Q2
44 quarters
|
|
2474
Forgent Power Solutions
FPS
$7.09B
| $38.9M | ﹤0.01% |
696,443
+373,925
| +116% | +$17.1M |
2026 Q1
1 quarter
|
|
2475
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.4B
| $38.9M | ﹤0.01% |
376,844
+27,827
| +8% | +$2.77M |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.